Stemming the opioid-induced pain cascade via cannabinoid modulation
通过大麻素调节阻止阿片类药物引起的疼痛级联反应
基本信息
- 批准号:10435486
- 负责人:
- 金额:$ 24.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAcuteAnalgesicsAnimal ModelAnimalsAnti-Inflammatory AgentsAntiinflammatory EffectAttentionAttenuatedBehaviorBehavioralBehavioral ModelBindingBiologicalCNR1 geneCNR2 geneCannabinoidsCannabisChemicalsChronicDataDepressed moodDevelopmentDiseaseDrug TargetingDrug abuseEndocannabinoidsEnzymesExperimental Animal ModelFemaleGeneticGlycerolGoalsGoldHarvestHumanHyperalgesiaImmunologicsIn VitroIncubatedIndividualInflammationInflammatoryInjuryLiteratureMAGL inhibitorMeasuresModelingMonoacylglycerol LipasesMorphineMorphine UsersMotivationMusNeedlestick InjuriesNeuronsOpiate AddictionOpioidPainPainlessPathway interactionsPerceptionPeripheralPersonsPharmaceutical PreparationsPharmacologyPhysiologicalPhysiological ProcessesPostoperative PainPostoperative PeriodPropertyQuality of lifeRelapseReportingResearchRiskSpinal CordSplenocyteStimulusSubstance Use DisorderSurfaceSurgical incisionsSurgical suturesTLR4 geneTestingTherapeuticTherapeutic InterventionThermal HyperalgesiasTissuesTranslational ResearchTreatment outcomeWithdrawalWomanabuse liabilityallodyniabasecannabinoid receptorcannabinoid receptor antagonistcombatconditioningcytokinedependence relapsedesensitizationdrug relapseeffective therapyendogenous cannabinoid systemexogenous cannabinoidinflammatory painmacrophagemalemarijuana usemechanical allodyniamonocytemorphine administrationmu opioid receptorsneurobehavioralnovel strategiesopioid abuseopioid epidemicopioid exposureopioid sparingopioid useopioid use disorderopioid useropioid withdrawalpain perceptionpain sensitivitypainful neuropathypreclinical studyprescription opioidpreventreceptorrelating to nervous systemresponsesexside effectstemsubstance abuse treatment
项目摘要
Despite their abuse potential, opioids remain a gold standard analgesic. One of the lesser
discussed effects of chronic opioid use is opioid induced hyperalgesia (OIH), or increased pain
sensitivity in some users. OIH persists for a longer duration than opioid withdrawal and may
contribute to drug seeking and relapse in people with substance use disorders. The
physiological causes of OIH are caused by (1) repeated µ opioid activation and desensitization,
and (2) activation of inflammatory pathways by morphine binding to Toll-like receptor 4.
Cannabinoids have well established analgesic and anti-inflammatory properties. Endogenous
cannabinoids (i.e., endocannabinoids) have anti-inflammatory effects with limited intoxicating
effects, as compared with exogenous cannabinoids. The proposed study will use an
experimental animal model of repeated morphine exposure, followed by paw incision injury. Our
goal is to test the hypothesis that inhibition of the endocannabinoid catabolic enzyme
monoacylglycerol lipase (MAGL) decreases pain and inflammation caused by repeated
morphine treatment. Male and female mice will be repeatedly administered morphine or vehicle,
in the presence of increased endocannabinoid tone, for four days. Endocannabinoid tone will be
increased by either chemical inhibition of MAGL, or genetic deletion of MAGL globally or on
neurons only. Then, a small incision will be made and sutured closed in the plantar surface of
one hindpaw, to model postoperative hyperalgesia. Mice will be tested repeatedly for pain-
induced, pain-suppressed, and pain conditioning behavioral models. Endocannabinoid receptor
mechanism will be determined using selective CB1 and CB2 cannabinoid receptor antagonists.
Paw tissue will be collected to quantify proinflammatory cytokine levels, and individual cytokine
levels will be correlated with pain-related behaviors. The anti-inflammatory mechanisms of
endocannabinoid modulation will be further probed in vitro, using isolated
macrophages/monocytes. Extant studies of preclinical OIH models have used male animals
almost exclusively. Because women may be at increased risk for developing OIH, we will
include sufficient numbers of both female and male mice to investigate Sex as a Biological
Variable. In addition to increasing basic understanding of the underlying neural and
immunological mechanisms that contribute to opioid-induced hyperalgesia, our translational
research goal is to develop treatments for substance abuse disorders.
尽管阿片类药物有滥用的可能性,但它们仍然是止痛药的黄金标准。其中一个较小的
讨论的长期使用阿片类药物的影响是阿片类药物诱导的痛觉过敏(OIH),或增加疼痛
一些用户的敏感性。OIH比阿片类药物戒断持续时间更长,
导致药物使用障碍患者的药物寻求和复发。的
OIH的生理原因是由(1)重复的μ阿片样物质激活和脱敏,
和(2)通过吗啡与Toll样受体4的结合激活炎症途径。
大麻素具有良好的镇痛和抗炎特性。内源
大麻素(即,内源性大麻素)具有抗炎作用,
与外源性大麻素相比,拟议的研究将使用一个
重复吗啡暴露的实验动物模型,随后是爪切口损伤。我们
目的是检验内源性大麻素分解代谢酶的抑制
单酰基甘油脂肪酶(MAGL)可减少由反复
吗啡治疗雄性和雌性小鼠将重复施用吗啡或媒介物,
在内源性大麻素浓度增加的情况下,持续四天。内源性大麻素的音调将是
通过MAGL的化学抑制或MAGL的遗传缺失而增加,
只有神经元。然后,在足底表面做一个小切口并缝合,
一只后爪,以模拟术后痛觉过敏。老鼠会被反复测试疼痛-
诱导、疼痛抑制和疼痛条件反射行为模型。内源性大麻素受体
将使用选择性CB 1和CB 2大麻素受体拮抗剂来确定机制。
将收集爪组织以定量促炎细胞因子水平和单个细胞因子
水平将与疼痛相关的行为相关。的抗炎机制
内源性大麻素调节将进一步探讨在体外,使用分离的
巨噬细胞/单核细胞。临床前OIH模型的现有研究使用雄性动物
几乎完全。因为女性可能会增加患OIH的风险,我们将
包括足够数量的雌性和雄性小鼠,以研究性别作为生物学指标,
变量除了增加对潜在的神经和
免疫机制,有助于阿片类药物诱导的痛觉过敏,我们的翻译
研究目标是开发药物滥用障碍的治疗方法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven G. Kinsey其他文献
#74 Steroid resistance and anxiety-like behaviors develop in aged, socially defeated CD-1 mice
- DOI:
10.1016/j.bbi.2005.10.080 - 发表时间:
2005-07-01 - 期刊:
- 影响因子:
- 作者:
Steven G. Kinsey;Michael T. Bailey;John F. Sheridan;David A. Padgett - 通讯作者:
David A. Padgett
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
- DOI:
10.1208/s12248-008-9075-y - 发表时间:
2009-01-29 - 期刊:
- 影响因子:3.700
- 作者:
Joel E. Schlosburg;Steven G. Kinsey;Aron H. Lichtman - 通讯作者:
Aron H. Lichtman
The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB<sub>2</sub> receptor activation
- DOI:
10.1016/j.neuropharm.2024.110216 - 发表时间:
2025-02-15 - 期刊:
- 影响因子:
- 作者:
Antonio Matt Reck;David P. Siderovski;Steven G. Kinsey - 通讯作者:
Steven G. Kinsey
Steven G. Kinsey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven G. Kinsey', 18)}}的其他基金
Stemming the opioid-induced pain cascade via cannabinoid modulation
通过大麻素调节阻止阿片类药物引起的疼痛级联反应
- 批准号:
10218325 - 财政年份:2021
- 资助金额:
$ 24.15万 - 项目类别:
Reducing the deleterious effects of synthetic cannabinoid withdrawal on emotionality and motivation
减少合成大麻素戒断对情绪和动机的有害影响
- 批准号:
10134039 - 财政年份:2020
- 资助金额:
$ 24.15万 - 项目类别:
Endocannabinoid modulation of affective signs of cannabinoid withdrawal
内源性大麻素对大麻素戒断情感体征的调节
- 批准号:
8806670 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Targeting multiple enzyme systems to reduce arthritic pain and inflammation
针对多种酶系统来减轻关节炎疼痛和炎症
- 批准号:
8878443 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
Operating Grants